Background: FBXL5 is required for proper regulation of cellular iron homeostasis. Results: FBXL5 contains a structurallycharacterized hemerythrin-like domain.
SUMMARY
Mammalian cells maintain iron homeostasis by sensing changes in bioavailable iron levels and promoting adaptive responses. FBXL5 is a subunit of an E3 ubiquitin ligase complex that mediates the stability of Iron Regulatory Protein 2, an important posttranscriptional regulator of several genes involved in iron metabolism. FBXL5's own stability is regulated in an iron-and oxygen-responsive manner, contingent upon the presence of its N-terminal domain. Here we present the atomic structure of FBXL5's N-terminus, a hemerythrin-like alpha-helical bundle fold not previously observed in mammalian proteins. The core of this domain employs an unusual assortment of amino acids necessary for the assembly and sensing properties of its diiron center. These regulatory features govern the accessibility of a mapped sequence required for proteasomal degradation of FBXL5. Detailed molecular and structural characterization of the ligand responsive hemerythrin domain provides insights into the mechanisms by which FBXL5 serves as a unique mammalian metabolic sensor.
Because both iron deficiency and iron overload can be deleterious, it is imperative that cells maintain proper iron homeostasis (1) . Cellular iron homeostasis is regulated in part by Iron Regulatory Protein 2 (IRP2), which posttranscriptionally regulates a cohort of iron metabolism genes (2) . IRP2 controls either the translation or stability of its target mRNAs by binding to RNA hairpin structures, known as ironresponsive elements (3, 4) . IRP2 accumulates under iron-or oxygen-deficient conditions but is polyubiquitinated and degraded by the proteasome when iron and oxygen are plentiful (5) (6) (7) . The physiological importance of IRP2 is reflected in the observed phenotypes arising from targeted gene deletion, including anemia and mild neurodegeneration (8) (9) (10) (11) . Proper IRP2 regulation necessitates that cells sense both iron and oxygen availability and a means by which such information effects an appropriate change in IRP2 stability. However, the mechanisms by which IRP2 is regulated in an iron-and oxygendependent manner are only beginning to be delineated.
Recently, we and others reported that an E3 ubiquitin ligase complex containing F-box and leucine-rich repeat protein 5 (FBXL5) regulates IRP2 stability (12, 13) . A reduction in FBXL5 expression leads to inappropriate accumulation of IRP2 and subsequent misregulation of IRP2 target genes in cultured cells, indicating that FBXL5 contributes to the maintenance of iron homeostasis. Notably, FBXL5 is regulated in an inverse fashion to IRP2, as it is stabilized under iron-replete conditions and preferentially degraded when iron or oxygen becomes limiting. Domain mapping studies revealed that the N-terminus of FBXL5 is required for its iron-dependent regulation. Bioinformatic analysis predicted the Nterminal region of FBXL5 encodes a hemerythrinlike domain (12, 13) .
Hemerythrin (Hr) domains are characterized by an alpha-helical bundle fold that commonly contains a diiron center (14) , though other metal centers are possible (15) (16) (17) (18) . These iron atoms are redox active and can switch between the fully oxidized diferric (met) state, a partially reduced semi-met state, and a fully reduced diferrous (deoxy) state. In canonical Hr domains, one iron atom (Fe1) is coordinated by the imidazole side chains from three histidines, while the other iron (Fe2) is coordinated by two histidines. Typically, a glutamate and an aspartate provide carboxylate groups that bridge Fe1 and Fe2 (14) . In the deoxy state, the iron atoms are also bridged by a µ -hydroxo species, ostensibly derived from the solvent. These hemerythrins often reversibly bind dioxygen to Fe2 with electron delocalization from both irons to the oxygen to form the oxy-state. A proton is also transferred from the bridging hydroxo to the resulting peroxo ligand. The hydroperoxo adduct is stabilized by a hydrogen bond to the µ -oxo bridge (19, 20) . Though not previously identified in any vertebrate proteins, the putative ligand-binding properties of the Hr domain make it an attractive candidate for a central iron-and oxygen-sensing module.
Here we report the crystal structure of the isolated FBXL5 Hr domain and characterization of key residues within this domain. These data reveal atypical features that allow FBXL5 to function via its N-terminal Hr domain as a ligand-dependent regulatory switch in the maintenance of iron homeostasis.
EXPERIMENTAL PROCEDURES
Protein expression and purification-The Nterminus of H. sapiens FBXL5 (residues 1-161) was cloned into the pGST-parallel1 vector and expressed in E. coli BL21 (DE3) cells grown in media supplemented with 100 µM FAC. Soluble FBXL5 Hr protein was purified using glutathione agarose (GE Healthcare). The GST fusion tag was cleaved upon incubation with TEV protease for 6 hr at 24°C and the liberated Hr domains were purified by anion exchange chromatography (HiTrap Q, GE Healthcare). Iron-loaded Hr was separated from apo Hr by an additional anion exchange (Mono Q, GE Healthcare) purification step. Purified FBXL5 Hr used to generate Native form 1 crystals was exchanged into a buffer composed of 24 mM Tris-HCl pH 8.0, 50 mM NaCl, 5 mM β-mercaptoethanol and 0.5 mM tris(2-carboxyethyl) phosphine using a centricon (VivaSpin MWCO 5kDa) and passed through a 0.22 µm filter.
Crystallization and X-ray diffraction data collection-Crystals of FBXL5 Hr (Native 1) were grown using the hanging-drop vapor-diffusion method from 1:1 (v/v) mixtures of protein (5 mg/ml) and reservoir solution (10% (w/v) PEG 6000, 0.1 M HEPES pH 6.5). Plate-like crystals appeared after 1 day at 20°C and grew to their maximal extent (0.2 x 0.5 x 0.1 mm) by 2-3 days. Cryoprotection was performed by stepwise transfer of the crystals to a final solution of 25% (v/v) ethylene glycol, 10% PEG 6000, and 0.1 M HEPES pH 6.5, followed by flash-cooling in liquid nitrogen.
Crystals of the second form of FBXL5 Hr (Native 2) were obtained using an identical purification scheme as Native 1, except that recombinant protein was exchanged into buffer lacking reducing agents and allowed to incubate at 4°C for 24 hr. Native 2 crystals were grown using the hanging-drop vapor-diffusion method from 1:1 (v/v) mixtures of protein (5 mg/ml) and reservoir solution (0.1 M HEPES pH 7.4, 25% (w/v) PEG 3350). Plate-like crystals appeared after 1 day at 20°C and grew to their maximal extent by 2-3 days. Cryoprotection was performed by stepwise transfer of the crystals to a final solution of 0.1 M HEPES pH 7.4, 25% PEG 3350, and 20% ethylene glycol prior to flash-cooling using liquid nitrogen. Native 2 crystals exhibited the symmetry of space group P2 1 with unit cell parameters of a=76.3 Å, b=54.4 Å, c=78.2 Å and β=90.02° and contained four molecules of FBXL5 Hr per asymmetric unit. Native 2 crystals displayed moderate anisotropy and P222 pseudosymmetry, and diffracted to a d min of 2.10 Å when exposed to synchrotron radiation.
Crystals of the third form of FBXL5 Hr (Native 3) were obtained using an identical purification scheme as Native 1 except that recombinant protein was exchanged into buffer containing 2 M equivalent Na 2 S 2 O 4 . Crystals were generated in an anaerobic chamber (Coy Laboratories) using the hanging-drop vapordiffusion method from 1:1 (v/v) mixtures of protein (5 mg/ml) and reservoir solution (12% (w/v) PEG 6000, 0.1M HEPES pH 6.5). Prior to usage, all reagents were purged with nitrogen gas for 30 minutes followed by an overnight incubation in an anaerobic chamber. Plate-like crystals appeared after 1 day at room temperature and grew to their maximal extent by 2-3 days. Cryoprotection was performed by stepwise anaerobic transfer of the crystals to a final solution of 30% (v/v) ethylene glycol, 12% PEG 6000, and 0.1 M HEPES pH 6.5, followed by flash-cooling in liquid nitrogen. Native 3 crystals exhibited the symmetry of space group C2 with unit cell parameters of a=60.4 Å, b=76.0 Å, c=77.4 Å and β=112.1° and contained two molecules of FBXL5 Hr per asymmetric unit. Native 3 crystals diffracted isotropically to a d min of 2.20 Å when exposed to synchrotron radiation. Data were indexed, integrated and scaled using the HKL-3000 program package (21) . Data collection statistics are provided in Table S1 .
Structure determination and refinementPhases for Native 1 crystals of FBXL5 Hr were obtained from a two-wavelength anomalousdispersion experiment using data to a resolution of 2.5 Å, collected near the iron absorption edge. Four iron and two sulfur sites were located using the program SHELXD (22) ; this represented two single-occupancy iron sites and one methionine sulfur site per FBXL5 Hr monomer. Phases were refined with the program MLPHARE (23), resulting in an overall figure-of-merit of 0.59 for data between 44.7 and 2.5 Å. Phases were further improved by density modification and two-fold non-crystallographic averaging with the program DM (24) , resulting in a figure-of-merit of 0.85. An initial model containing about 86% of all residues was automatically generated by alternating cycles of the programs ARP/warp (25) . Additional residues were manually modeled in the program O (26) . Refinement was performed with native data to a resolution of 1.85 Å using the program PHENIX (27) , with a random 5.1% of all data set aside for R free calculations. All atoms in the protein were restrained in a similar manner, using restraints provided by the PHENIX refinement program. No explicit metal-ligand restraints were added.
Phases for the Native 2 and Native 3 crystals of FBXL5 Hr were obtained via molecular replacement in the program PHASER (28) Table  S1 .
EPR Spectroscopy-X-band EPR spectra were recorded using a Bruker Elexsys E-500 spectrometer equipped with an Oxford Instruments ESR-10 liquid helium cryostat, under the following conditions unless otherwise indicated: temperature 10 K, modulation amplitude 1 mT, and 5 mW microwave power, with 200-500 µM FBXL5 Hr as estimated by a calculated molar extinction coefficient of 19.3 mM -1 cm -1 at 280 nm. Reduction of the FBXL5 hemerythrin domain was achieved through the anaerobic addition of 3 molar equivalents of Na 2 S 2 O 4 in the presence of 20 µM methyl viologen in a Coy anaerobic chamber. The samples were transferred into sealed quartz EPR tubes and frozen in liquid N 2 . EPR quantification was performed through comparison with a 1 mM copper perchlorate spin standard under non-saturating conditions. Determination of the exchange coupling constant of mixed-valent FBXL5 Hr were conducted as previously described (29) .
Stopped-Flow Kinetics-Experiments were performed using an Applied Photophysics Ltd. SX.18.MV stopped-flow spectrophotometer. Following reduction, excess Na 2 S 2 O 4 and methyl viologen were removed using a PD-10 desalting column (Amersham) before loading into an anaerobic stopped flow syringe. Reduced FBXL5 Hr (200 µM) was rapidly mixed with O 2 -saturated buffer at 4°C (~1.8 mM). The rate of FBXL5 oxidation at 340 nm under pseudo first order conditions was fit to a summed exponential expression using Pro-K software (Applied Photophysics).
Cell Culture and Reagents-All cell lines were grown in Dulbecco's Modified High Glucose Eagles Medium (Hyclone) supplemented with 10% fetal bovine serum (Atlanta Biologicals). Plasmid DNA and siRNA transient transfections were performed as previously described (12) . Low-O 2 experiments were performed in a hypoxic incubator (Coy Laboratory Products Inc) containing 1% O 2 , 5% CO 2 and balance N 2 . HEK 293 cells stably expressing the 3X FLAG-Hr-HA construct was generated over two rounds of clonal selection in the presence of 400 µg/mL G418 (Research Products Inc). Ts-20 BALB/c 3T3 cells were kindly provided by H. Ozer.
Plasmids-Wild-type, H57A, and E61A human FBXL5 were cloned into the pCI FLAG vector (kindly provided by X. Wang) as previously described (12) . The FBXL5 H15A construct was generated using a triple ligation approach. A 5' DNA fragment containing the H15A mutation was purchased from IDT technologies. This fragment was amplified using the oligonucleotide 5'-GGAGAGATCTCAGACCATTTATAATGTAC ATTCTGACAATAAACTC and a previously described WT FBXL5 forward primer (12) . The remaining 3' fragment was amplified from FBXL5 plasmid DNA using the oligonucleotide 5'-GGAGAGATCTCAGACCATTGCAGCTGCAC ATGCTGACAATAAACTCTCCGAGATGCTT and a previously described WT FBXL5 reverse primer (12) . The resulting fragments were ligated together via an artificially inserted BglII site and inserted into the pCI FLAG vector at the BamHI and SalI sites. The oligonucleotide 5'-GAGGGTC GACTCAAGCGTAATCTGGAACATCGTATG GGTACTGAGAGCAGTGTTGTGC was used to incorporate a C-terminal HA tag into the FBXL5 1-161 pCI FLAG plasmid. The remaining FBXL5 mutant and deletion constructs were generated by either standard methods or by the PCR overlap extension method using the oligonucleotides as listed in Table S4 . For constructs containing a V5 epitope tag the pcDNA 3.1 vector (Invitrogen) was used while constructs containing a FLAG epitope were generated in the pCI vector.
Immunoblot Analysis-Samples were resuspended in SDS sample buffer and proteins were resolved by SDS-PAGE. Mouse monoclonal antibodies were obtained as follows: α-FLAG (Sigma, cat# F3165), α-V5 (Invitrogen, cat# R960-25), α-tubulin (Sigma, cat# T6199), and α-ubiquitin (Santa Cruz, cat# sc-8017). Quantitation of immunoblots for Table S5 .
Ubiquitination Assays-HEK 293T cells stably expressing an N-terminal 3X FLAG tagged FBXL5 construct (12) were treated with or without 30 µM MG132 (Boston Biochem) for 1 hr followed by addition of 50 µM ferric ammonium citrate (FAC; Sigma) or 50 µM deferoxamine mesylate (DFO; Sigma). Cells were then incubated for 6 hours. Cell extracts were prepared by adding lysis buffer containing 50 mM Tris-HCl pH 8, 150 mM NaCl, 1% triton X-100, 250 µM phenylmethysulfonyl fluoride (Sigma), 1X protease inhibitor cocktail (Sigma) and 10 mM Nethylmaleimide. Lysates were incubated 20 min at 4°C, and cysteine (0.1% final conc.) was added to neutralize the N-ethylmaleimide. Lysates were clarified by centrifugation at 17,000 x g for 20 min and protein concentration was determined by the Bradford assay (Bio-Rad). Lysates (~1 mg) were incubated with 12 µL of FLAG M2 resin (Sigma) overnight to immunoprecipitate FBXL5. Resin was washed three times with lysis buffer, and immunoprecipitated protein was eluted using FLAG peptide. Proteins were resolved by SDS-PAGE and analyzed by immunoblotting. The ubiquitination assay of the FBXL5 hemerythrin domain was carried out as described using HEK 293 cells stably expressing the N-terminal 3X FLAG and C-terminal HA tagged FBXL5 hemerythrin domain construct (HEK-Hr). To suppress endogenous FBXL5 expression, HEK-Hr cells were transfected with a FBXL5 siRNA (Dharmacon, cat# D-012424-04) and a nontargeting siRNA (Dharmacon, cat# D-001210-01) for 48 hr.
RESULTS
The N-terminus of FBXL5 adopts a hemerythrin fold-Recombinant FBXL5 Hr was purified under ambient oxygen conditions ( Fig. S1  A and B) . The EPR spectrum of the as-isolated Hr (Fig. 1, spectrum 1) shows an S=1/2 signal with gvalues of 1.95, 1.80, and 1.67 (Fig. 1, inset) , typical of diiron enzymes in the mixed valent state in which antiferromagnetic coupling of high-spin Fe III (S=5/2) and Fe II (S=2) can be observed (29) (30) (31) . Reduction with excess sodium dithionite results in the disappearance of this signal, and no additional EPR signal can be observed in either perpendicular (Fig. 1, spectrum 2 ) or parallel modes (data not shown), consistent with formation of the diferrous state. Spin quantification shows that the EPR-active mixed-redox state represents only a minor (5-10%) fraction of the total protein.
The majority of the as-isolated FBXL5 Hr likely resides in the EPR-silent (S=0) diferric resting state based on the intense optical feature at 340 nm (Fig. S1C ) that originates from an oxo to ferric ion charge-transfer transition.
Crystals of the FBXL5 Hr were generated under ambient oxygen conditions. An X-ray fluorescence scan of these crystals displayed a maximum at an incident energy of 7.12 keV. This energy closely corresponds to the absorption edge of iron (32) , implying that this metal is bound to the protein. These Native 1 crystals exhibited the symmetry of space group C2 with unit cell parameters of a=60.1 Å, b=75.8 Å, c=78.7 Å and β=111.8° and contained two molecules of FBXL5 Hr per asymmetric unit. Native 1 crystals diffracted isotropically to a d min of 1.85 Å when exposed to synchrotron radiation (Native form 1, Table S1 ). The current model for the Native 1 crystals contains two FBXL5 Hr monomers and includes residues 4-74, 77-80, 84-159 from molecule A and residues 4-74, 77-80, 84-160 from molecule B along with 168 waters. The R work is 0.170, and the R free is 0.211. A Ramachandran plot generated with Molprobity (33) indicated that 98.3% of all protein residues are in the most favored regions with the remaining 1.7% in additionally allowed regions.
While FBXL5 Hr's up-down alpha-helical bundle featuring a diiron center is consistent with the tertiary structure of previously-characterized hemerythrins (Fig. S2A) , there are several unusual features present in this Hr, including a fifth helix packed against the apex of the canonical bundle ( Fig. 2A) . Overall, the FBXL5 Hr has a similar diameter (~20 Å) but greater length (58 Å) relative to other hemerythrin structures (~40-50 Å) (34, 35) and is most structurally homologous to the oxygen-responsive Hr from the bacterial DcrH protein (Fig. S3) . In canonical Hr structures, each of the iron-ligating residues is positioned within an alpha helix (14) . However, in the FBXL5 Hr, helix α3 is relatively short and does not extend through H80, one of the seven residues comprising the primary iron-coordination shell. Instead, this residue exists in a small ordered region that is in a partially disordered loop preceding helix α3 (Fig.  2 and Fig. S3A ). The coordination geometry of the FBXL5 Hr diiron site also differs from those of canonical hemerythrins. As noted in Table S2 , the Fe-Fe distance is shorter in the FBXL5 Hr (3.12 Å versus ~3.34-3.41 Å) than other hemerythrins (14, 35) , and the FBXL5 Hr Fe-O µ -Fe angle is more acute (98.1°) than those previously observed in invertebrate (116.7°) and bacterial (132.4°) hemerythrins (14, 35) . Moreover, the core iron atoms are positioned closer to the apex of the bundle in the FBXL5 Hr (Fig. S3B) .
Iron binding by the hemerythrin domain is required for FBXL5's stability-Examination of the amino acid side chains responsible for coordinating iron (Figs. 2B and 2C ) reveals differences between FBXL5's diiron center and the consensus observed in the majority of hemerythrins. In place of an aspartate and glutamate to bridge the diiron center, the FBXL5 Hr employs two glutamates (E61 and E130). As most Hr domains studied to-date employ five coordinating histidines, the most significant variation in the FBXL5 Hr diiron center is the presence of an additional glutamate (E58) in lieu of a third histidine binding Fe1. Interestingly, the distance between Oε2 of E58 and the bridging oxygen is ~2.8 Å (Table S2 ) with an O µ -Oε2-Cγ angle of ~106°. This geometry is consistent with E58 forming a hydrogen bond with a µ -oxygen species (Fig. S2B) .
To confirm the critical roles of the observed iron-ligating residues to iron-dependent regulation of FBXL5, each residue was individually mutated to an alanine. The resulting expression constructs were transfected into HEK 293T cells prior to treatment with the iron chelator DFO or the iron species ferric ammonium citrate (FAC). In contrast to wild-type (WT) FBXL5, which preferentially accumulates under iron-replete conditions, all seven mutant proteins displayed constitutively low accumulation levels (Fig. 3A) that could be rescued by addition of the proteasome inhibitor MG132 (Fig. S4A) . In addition to these direct iron-binding ligands, the FBXL5 Hr structure indicated that residues N62, E131, and H158 form hydrogen bonds with the primary coordination shell residues H80, H15, and H57, respectively (Fig. 2B) . We postulated that these secondary-shell interactions might be crucial for the stable formation of the diiron center by bringing the imidazole moieties of residues H80, H15, and H57 into their optimal conformations to coordinate iron. Constructs containing mutations to secondary shell residues (N62A, E131A, and H158A) were transiently transfected into HEK 293T cells, and they, too, displayed lowered protein levels under both iron-replete and deficient conditions (Fig. S4B) . Loss of the additional fifth helix (Δ143-161), found in few other hemerythrinlike structures (15) , also led to constitutive destabilization of FBXL5 (Fig. S4C) . This result was expected, given the importance of the secondary coordination shell residue H158 within helix α5.
In the FBXL5 Hr domain, Fe1 is ligated by two histidines (H126 and H80) and a glutamate (E58) that appears to make a hydrogen bond with the bridging, solvent-derived oxygen atom. In order to directly interrogate whether this unique ligand environment alters the electronics of the diiron site, we determined the exchange coupling constant J of the mixed-valent FBXL5 Hr to be 120 cm -1 (Fig. S5) . This large value is suggestive of an oxo bridge, rather than a hydroxo bridge (J < 20 cm -1 ) as observed for mixed-valent forms of the canonical Hr (30,31) (Table S3) . Hence, unlike Hr and other diiron enzymes, in which reduction from the diferric to the mixed valent state is accompanied by protonation of the single atom bridge, the bridge of FBXL5 is likely retained as an oxo-ligand.
To determine whether this unusual arrangement was required for Hr function, FBXL5 E58 was mutated to a histidine (E58H). As observed for the E58A variant, E58H FBXL5 was constitutively unstable following both FAC and DFO treatment (Fig. 3B) . Likewise, when residue E58 was mutated to aspartate (E58D) or glutamine (E58Q), FBXL5 was again unstable and unresponsive to iron (Fig. 2C) . The failure of histidine or aspartate to functionally substitute for E58 could be due to steric constraints. Modeling indicates that there is an uncommon, high-energy His rotamer that could place the Nδ1 atom within 2.8 Å of the iron. However, a more common, lowenergy rotamer position for H58 would place the Nε2 atom 3.7 Å from Fe1, too far away to function as an iron ligand. Similarly, aspartate at position 58 would place a carboxylate oxygen ~2.6 Å from Fe1, which is still rather far for an iron ligand, while the second carboxylate oxygen is also too far from the µ -hydroxo atom to function as a hydrogen bond acceptor. Moreover, a glutamine at position 58 also fails to bind iron (data not shown) and restore proper iron responsiveness (Fig. 3B) , even though its carboxamide oxygen can on rare occasions ligate iron. Together, these data suggest that FBXL5 induction in response to increased iron bioavailability requires an intact Hr domain capable of assembling a diiron center with unusual ligands.
FBXL5 is polyubiquitinated and degraded by the proteasome under iron-deplete conditions-
Destabilization of FBXL5 upon iron depletion is dependent on the proteasome (12). To determine if FBXL5's proteasome sensitivity is accompanied by polyubiquitination in an iron-dependent fashion, HEK 293T cells stably expressing FBXL5-FLAG were treated with either FAC or DFO in the absence or presence of MG132, and FBXL5-FLAG was immunoprecipitated. As shown in Figure 4A , FBXL5 is polyubiquitinated under iron-deficient conditions. However, when iron is plentiful, the extent of the laddering characteristic of heterogeneous polyubiquitination is diminished (Fig. 4A) . These data are consistent with bioavailable iron levels regulating FBXL5 via its polyubiquitination status.
Similar to full-length FBXL5, the isolated FBXL5 Hr domain is preferentially polyubiquitinated under iron-deficient conditions (Fig. 4B) . To further confirm that ubiquitination is required for FBXL5 Hr degradation, a murine ts-20 BALB/c 3T3 fibroblast cell line featuring a temperature-sensitive E1 variant (36,37) was transfected with a FLAG-Hr-HA construct. At the E1 permissive temperature (35°C), FLAG-Hr-HA levels diminish upon a shift from iron replete conditions to iron deplete conditions (Fig. 4C) . At the restrictive temperature (39°C), loss of E1 activity globally compromises polyubiquitination and degradation of substrates by the ubiquitinproteasome system (UPS) (37, 38) . Under these conditions, FLAG-Hr-HA protein accumulation levels remain high, even upon addition of DFO (Fig. 4C) . Likewise, a functional UPS is required for FBXL5 Hr degradation under low O 2 conditions (Fig. 4D) .
As the F-box subunits of Skp1/Cul1/F-box (SCF) E3 ubiquitin ligase complexes can be subjected to autoubiquitination (39), we suspected that SCF FBXL5 might itself be the responsible Hr E3 ligase. However, the isolated Hr lacks a F-box domain, and thus cannot assemble into an SCF E3 ligase complex, arguing against an autoubiquitination model. To exclude the possibility that SCF FBXL5 could ubiquitinate the FBXL5 Hr domain in trans, endogenous FBXL5 was depleted from HEK-Hr cells using a siRNA selectively targeting the full-length FBXL5 mRNA. Though FBXL5 knockdown was sufficient to stabilize IRP2, no effect on accumulation or ubiquitination status of the isolated Hr domain was observed (Fig. 4B) . These data suggests that another, hitherto unidentified E3 ubiquitin ligase activity is required for FBXL5 regulation conferred through its Hr domain.
To map an element within the FBXL5 Hr domain that is required for targeting the protein for degradation, a series of progressively longer FBXL5 N-terminal truncation constructs were generated. Because such large truncations were expected to compromise assembly of the diiron center, and consequently Hr integrity, it was postulated that all deletions would produce ironinsensitive and constitutively unstable products. While the ∆1-33, ∆1-59, and ∆1-76 proteins were predictably unstable, the ∆1-81 and ∆1-100 proteins accumulated to high levels following both FAC and DFO treatment (Fig. 3C) suggesting there is a regulatory sequence required for FBXL5 degradation located C-terminal to residue I76. To better delineate this sequence, we generated a series of FBXL5 constructs containing adjacent 5 amino acid deletions in the region spanning residues 67 to 91. Interestingly, deletion of residues 77-81 was sufficient to confer a substantial constitutive increase in FBXL5 accumulation (Fig. 4E) despite the fact that loss of H80 should preclude any iron binding. We propose that these residues are a required part of a regulatory sequence mediating FBXL5 proteasomal degradation. Notably, this sequence resides in the unusual extended loop joining helices α2 and α3 ( Fig. 2A and Fig S3A) .
Oxygen-dependent regulation of FBXL5-IRP2 degradation is induced by both high iron and high oxygen availability (5, 6) and is proposed to be largely conferred through the effects of iron and oxygen on FBXL5 (40) . Similar to ectopically expressed FBXL5 (12) , endogenous FBXL5 accumulation in the presence of excess iron is attenuated in a proteasome-dependent manner when cells are incubated under low O 2 conditions (Chollangi et al, manuscript in preperation). The isolated FBXL5 Hr domain also directly responds to O 2 ( Fig. 4D) suggesting that oxygen availability affects the stability of FBXL5 via polyubiquitination and proteasomal degradation mediated by its Hr domain.
The majority of previously characterized hemerythrins have been shown to reversibly bind oxygen at the diiron center (34, 41, 42) . While FBXL5 and its Hr domain are clearly regulated in an oxygen-dependent manner, no ordered electron density corresponding to O 2 was observed at the diiron center of the FBXL5 Hr crystal structure (Fig. 2B) . Interestingly, neither FBXL5 Hr structures derived from crystals grown in the absence of reducing agent (Native form 2, Table  S1 ) nor under anoxic conditions in the presence of excess dithionite reductant (Native form 3, Table  S1 ) were appreciably different (Fig. S6A) .
Closer examination of the FBXL5 Hr diiron center reveals that molecular oxygen would not be able to bind to the diiron center in these structures. When comparing FBXL5 Hr and the O 2 -binding DcrH Hr, the spatial conservation of the ironligating residues with respect to the diiron center is remarkably similar though there are significant spatial variations in the hydrophobic amino acids lining the putative O 2 -binding pockets (Fig. 5A) . In the FBXL5 Hr, F123 is positioned toward the center of the helical bundle and in close proximity (~4 Å) to the bridging µ -oxygen atom. M127 is also positioned closely (~4 Å) to both the bridging oxygen atom and Fe2. In the DcrH Hr crystal structure (35) , W114, the corresponding hydrophobic residue to F123, is near the periphery of the hydrophobic core adjacent to Fe1. The analogous residue to M127 in the DcrH Hr, L115, is more distal (~6 Å) to both Fe2 and the bridging oxygen. Consequently, the binding pocket in the DcrH Hr has much larger dimensions than the FBXL5 Hr site and can accommodate an O 2 molecule. In fact, there is not even sufficient room to model a molecule of water solvent in the Fe2 coordination site. Thus, substantial rearrangements to the FBXL5 Hr core would be required for ligand binding.
Rapid mixing of diferrous FBXL5 with saturating dioxygen results in the rapid reappearance (t 1/2~2 50 msec) of the Fe-oxo charge transfer band at 340 nm with no other transient intermediate accumulating prior to reoxidation to the diferric resting state (Fig. 5B) . In particular, no oxygenated form of the enzyme, such as an end-on hydroperoxo moiety observed in P. gouldii Hr (ε ~2000 M -1 cm -1 at 500 nm) or a µ-1,2 peroxo adduct (typically observable at ~700 nm) can be observed following dioxygen addition. Thus, while the oxidation state of the FBXL5 Hr diiron center responds to O 2 availability, its degron accessibility is not likely to be regulated by conformational changes stemming from reversible binding of O 2 .
DISCUSSION
Here we employed structural and molecular approaches to characterize the Hr domain that mediates regulation of the E3 ligase subunit, FBLX5. X-ray crystallography demonstrated the isolated FBXL5 N-terminus adopts a hemerythrinlike alpha-helical bundle fold stabilized by a diiron center. Nevertheless, this mammalian Hr contains several unique attributes that could contribute to its switch-like properties including 1) a required fifth helix contributing a residue in the secondary iron coordination shell, 2) a non-canonical primary iron ligand that also makes an apparent hydrogen bond contact with the bridging solvent-derived oxygen atom, 3) crowded side-chain packing within the presumptive O 2 binding site, and 4) a truncated helix α3 preceded by several disordered amino acids and an extended loop that contains an important regulatory element.
Under iron-and oxygen-replete conditions, both FBXL5 and its isolated Hr are resistant to polyubiquitination and proteasomal degradation. Compromising formation of the diiron center, either through chelation of bioavailable iron or by mutation of any residue within the primary or secondary iron-coordination spheres, leads to increased degradation of FBXL5. The requirement for E1 activity suggests that ubiquitination is required for FBXL5 degradation. Though the responsible E3 ligase has not yet been identified, residues 77-81 appear to act as part of a functional degron as deletion of this region stabilizes the protein, despite the Hr domain's inability to bind iron upon removal of H80. We propose that in the absence of iron binding, this regulatory sequence becomes fully accessible, promoting a large induction in the extent of polyubiquitination and proteasomal degradation.
Despite our efforts to crystallize both oxidized and fully reduced forms of FBXL5 Hr, the resulting structures do not display statistically significant differences in bond distances or angles of the diiron centers. Given the observed Fe1-Fe2 distances (Table S2 ) and preparation conditions, it's most likely that these structures all represent a mixed-valent or diferric state. However, the observation of a putative hydrogen bond between E58 and the bridging oxygen atom is difficult to reconcile if the FBXL5 is present in the met or semi-met state in the crystal. Under the working buffer conditions (pH 6.5 and 7.4), the probability that E58 is protonated and serving as a hydrogen bond donor to a µ-oxo bridge is small, particularly as it is serving as an iron ligand. Only the reduced diferrous Hr could provide a requisite H-bond donating µ-hydroxyl group as both the diferric and mixed-valent semi-met states feature a µ -oxo bridge. As crystallization could trap a minor reduced species, or the oxidation state of the Hr could change during crystal manipulations (43), we cannot unambiguously assign the oxidation states of our crystals.
Among the Hr domain structures solved to date, the FBXL5 Hr is most structurally homologous to the bacterial DcrH Hr, an O 2 sensor within a bacterial chemotaxis protein (35, 42) . The DcrH Hr contains a putative substrate channel that is thought to facilitate diffusion of O 2 to the diiron center. Oxygen binding to the DcrH Hr causes a subtle conformational change in an N-terminal loop, which may drive further conformational changes within the full-length DcrH protein to govern its aerotactic signaling function (35) .
Instead of a channel, there is a large solvent accessible surface near Fe1 of the FBXL5 Hr diiron center facilitating oxygen exposure (Fig.  S7) . However, FBXL5 does not have an analogous N-terminal loop and, based on the structures presented here, it would have to undergo a substantial conformational change displacing residues F123 and M127 to accommodate an O 2 ligand at the Fe2 site. Another potential hindrance to O 2 binding the diiron center is residue E58, which appears to engage the bridging oxygen in a hydrogen bond interaction. Moreover, no evidence for transient O 2 binding was observed during reoxidation experiments or in the structures themselves even though oxygen was present throughout two of the three protein and crystal preparations. Alternatively, the O 2 -responsiveness observed for the isolated Hr domain in vitro and in cell culture studies could originate from electron transfer through outer sphere amino acid ligands.
Overall, the data presented here are consistent with a model in which FBXL5's N-terminal Hr domain senses both iron and oxygen to regulate FBXL5 stability. When intracellular iron levels are abundant, the Hr domain binds iron and adopts a conformation in which a degron containing residues 77-81 is sequestered. Notably in these crystal structures, the loop from residues 74-83 is not well ordered as evidenced by the high atomic displacement parameters for this region (Fig.  S6B ). This feature is unique to the FBXL5 Hr domain and overlaps a key regulatory element required for degradation. It is tempting to hypothesize that low oxygen conditions facilitate a physiologically-relevant increase in accessibility of helix α3, predisposing the FBXL5 Hr domain to enhanced degradation. 
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